Clinical virology faces challenges of opposing sign. On one hand, there will be an increasing demand for identification of novel pathogenic viruses, for resistance testing in a new era of antiviral therapy, and for full participation in the molecular revolution in diagnostic technologies. On the other hand, the responsibilities of clinical virology are being transferred to the general diagnostic microbiology laboratory, that risks limiting the numbers of specialists in virology available for meeting future challenges and demands.